Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis

Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis

The advantages of peritoneal dialysis (PD) over hemodialysis (HD) are well-documented. Notwithstanding, only a small proportion of patients with end-stage renal disease (ESRD) are managed with PD. This may be related to the high glucose load that PD solutions in current use have on the patient. The...

Full description

Bibliographic Details
Main Authors: Mario Bonomini, Lorenzo Di Liberato, Victor Zammit, Arduino Arduini
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Molecules
Subjects:
carnitine
end-stage renal disease
peritoneal dialysis
osmolyte
Online Access:https://www.mdpi.com/1420-3049/24/19/3449

Internet

https://www.mdpi.com/1420-3049/24/19/3449

Similar Items